Drug Profile
TV 48108
Alternative Names: 48108; TEV-48108; TV48108Latest Information Update: 28 May 2018
Price :
$50
*
At a glance
- Originator Teva Branded Pharmaceutical Products R&D
- Class Bronchodilators
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Chronic obstructive pulmonary disease
Most Recent Events
- 28 May 2018 No recent reports of development identified for phase-I development in Chronic-obstructive-pulmonary-disease in Australia (Inhalation)
- 28 May 2018 No recent reports of development identified for phase-I development in Chronic-obstructive-pulmonary-disease in New Zealand (Inhalation)
- 28 May 2018 No recent reports of development identified for phase-I development in Chronic-obstructive-pulmonary-disease in USA (Inhalation)